<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(15)</volume><submitter>Moreau C</submitter><journal>Annals of translational medicine</journal><pagination>973</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7475393</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>How to quantify monoclonal free light chains in plasma cell disorders: which mass spectrometry technology?</pubmed_title><pmcid>PMC7475393</pmcid><pubmed_authors>Decaux O</pubmed_authors><pubmed_authors>Lefevre CR</pubmed_authors><pubmed_authors>Moreau C</pubmed_authors></additional><is_claimable>false</is_claimable><name>How to quantify monoclonal free light chains in plasma cell disorders: which mass spectrometry technology?</name><description/><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Aug</publication><modification>2025-04-25T17:38:46.885Z</modification><creation>2025-04-06T06:02:41.734Z</creation></dates><accession>S-EPMC7475393</accession><cross_references><pubmed>32953773</pubmed><doi>10.21037/atm.2020.03.200</doi></cross_references></HashMap>